Sanofi-Aventis SA has agreed to pay $33 million upfront to the Dana-Farber Cancer Institute in Boston, Massachusetts for access to its oncology research. Sanofi will be working with Dana-Farber’s Belfer Institute of Applied Cancer Science.
Sanofi-Aventis SA has agreed to pay $33 million upfront to the Dana-Farber Cancer Institute in Boston, Massachusetts for access to its oncology research. Sanofi will be working with Dana-Farber’s Belfer Institute of Applied Cancer Science.